When will there be coronavirus treatments and vaccines?
On the vaccine’s side
As a long-term solution against the disease, the creation of a vaccine requires a delay of several months between its conception and its marketing. Work is currently at the preclinical stage.
- In the United States, the first clinical trial to test a vaccine began Monday. mRNA-1273 was developed by scientists from the US National Institutes of Health (NIH) and the US biotech company Moderna. The trials will be conducted in 45 adult volunteers for about six weeks, the NIH said in a statement. If all goes well, it could be available within 12 to 18 months.
- Europe is also in the race to develop a vaccine, with the German company CureVac having announced that it will be able to start its first trials within the next few months. The President of the European Commission, Ursula von der Leyen, confirmed on Tuesday the payment of financial support of 80 million euros to accelerate the process, referring to possible marketing “before autumn”.